Steven W. Remmenga

6.5k total citations
20 papers, 720 citations indexed

About

Steven W. Remmenga is a scholar working on Obstetrics and Gynecology, Molecular Biology and Oncology. According to data from OpenAlex, Steven W. Remmenga has authored 20 papers receiving a total of 720 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Obstetrics and Gynecology, 7 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Steven W. Remmenga's work include Endometrial and Cervical Cancer Treatments (6 papers), Uterine Myomas and Treatments (5 papers) and Hippo pathway signaling and YAP/TAZ (3 papers). Steven W. Remmenga is often cited by papers focused on Endometrial and Cervical Cancer Treatments (6 papers), Uterine Myomas and Treatments (5 papers) and Hippo pathway signaling and YAP/TAZ (3 papers). Steven W. Remmenga collaborates with scholars based in United States, China and Saudi Arabia. Steven W. Remmenga's co-authors include John S. Davis, Cheng Wang, Jixin Dong, Subodh M. Lele, Peixin Yang, Chunbo He, Guohua Hua, Xiangmin Lv, Kerry J. Rodabaugh and Guoqiang Hua and has published in prestigious journals such as Oncogene, The Lancet Oncology and Cancer Letters.

In The Last Decade

Steven W. Remmenga

20 papers receiving 701 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven W. Remmenga United States 13 347 227 157 98 89 20 720
L. Moretti Belgium 9 148 0.4× 65 0.3× 144 0.9× 41 0.4× 57 0.6× 23 457
Dilu Feng China 14 370 1.1× 44 0.2× 180 1.1× 84 0.9× 99 1.1× 26 649
Bibo Yuan China 9 270 0.8× 130 0.6× 141 0.9× 45 0.5× 32 0.4× 17 465
Mingzi Tan China 16 339 1.0× 42 0.2× 125 0.8× 57 0.6× 160 1.8× 28 615
Bilan Li China 14 295 0.9× 40 0.2× 93 0.6× 70 0.7× 85 1.0× 20 613
Nana Tchabo United States 14 326 0.9× 36 0.2× 235 1.5× 133 1.4× 107 1.2× 25 744
Shogo Shigeta Japan 15 240 0.7× 36 0.2× 111 0.7× 118 1.2× 45 0.5× 50 525
Gemma Toledo Spain 12 324 0.9× 27 0.1× 187 1.2× 89 0.9× 50 0.6× 22 637
Songshu Xiao China 18 280 0.8× 25 0.1× 124 0.8× 243 2.5× 99 1.1× 46 810
Xiangdong Hua China 11 544 1.6× 131 0.6× 95 0.6× 17 0.2× 43 0.5× 20 764

Countries citing papers authored by Steven W. Remmenga

Since Specialization
Citations

This map shows the geographic impact of Steven W. Remmenga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven W. Remmenga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven W. Remmenga more than expected).

Fields of papers citing papers by Steven W. Remmenga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven W. Remmenga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven W. Remmenga. The network helps show where Steven W. Remmenga may publish in the future.

Co-authorship network of co-authors of Steven W. Remmenga

This figure shows the co-authorship network connecting the top 25 collaborators of Steven W. Remmenga. A scholar is included among the top collaborators of Steven W. Remmenga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven W. Remmenga. Steven W. Remmenga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Soliman, Amr S., Robert M. Chamberlain, Ahmed Hablas, et al.. (2021). Impact of hysterectomy on uterine cancer incidence rates in Egypt. Obstetrics & Gynecology International Journal. 12(1). 1 indexed citations
2.
Hablas, Ahmed, Robert M. Chamberlain, Jane L. Meza, et al.. (2019). Changing Incidence of Uterine Cancer in Rural Egypt: Possible Impact of Nutritional and Epidemiologic Transitions. Journal of Global Oncology. 5(5). 1–7. 2 indexed citations
3.
Soliman, Amr S., Ahmed Hablas, Mohamed Ramadan, et al.. (2018). Changes in Uterine Cancer Incidence Rates in Egypt. Obstetrics and Gynecology International. 2018. 1–10. 12 indexed citations
4.
Schmidt-Grimminger, Delf, Baojiang Chen, KM Monirul Islam, et al.. (2018). HPV Prevalence and its Association with Perinatal Outcomes among Singleton Mothers: Analysis of Pregnancy Risk Assessment and Monitoring System (PRAMS) Data, 2004-2011. Current Women s Health Reviews. 15(2). 143–149. 1 indexed citations
5.
Lv, Xiangmin, Chunbo He, Cong Huang, et al.. (2017). G-1 Inhibits Breast Cancer Cell Growth via Targeting Colchicine-Binding Site of Tubulin to Interfere with Microtubule Assembly. Molecular Cancer Therapeutics. 16(6). 1080–1091. 33 indexed citations
6.
Hua, Guoqiang, Chunbo He, Xiaozhen Lv, et al.. (2016). The four and a half LIM domains 2 (FHL2) regulates ovarian granulosa cell tumor progression via controlling AKT1 transcription. Cell Death and Disease. 7(7). e2297–e2297. 32 indexed citations
7.
He, Changjiu, Xin Lv, Guoqiang Hua, et al.. (2015). YAP forms autocrine loops with the ERBB pathway to regulate ovarian cancer initiation and progression. Oncogene. 34(50). 6040–6054. 84 indexed citations
8.
Hua, Guoqiang, Xin Lv, Changjiu He, et al.. (2015). YAP induces high-grade serous carcinoma in fallopian tube secretory epithelial cells. Oncogene. 35(17). 2247–2265. 59 indexed citations
9.
He, Chunbo, Dagan Mao, Guohua Hua, et al.. (2015). The Hippo/ YAP pathway interacts with EGFR signaling and HPV oncoproteins to regulate cervical cancer progression. EMBO Molecular Medicine. 7(11). 1426–1449. 211 indexed citations
10.
Singh, Ajay P., Shantibhusan Senapati, Moorthy P. Ponnusamy, et al.. (2008). Clinical potential of mucins in diagnosis, prognosis, and therapy of ovarian cancer. The Lancet Oncology. 9(11). 1076–1085. 90 indexed citations
11.
Ponnusamy, Moorthy P., Ganesh Venkatraman, Ajay P. Singh, et al.. (2007). Expression of TAG-72 in ovarian cancer and its correlation with tumor stage and patient prognosis. Cancer Letters. 251(2). 247–257. 34 indexed citations
12.
Molpus, Kelly L., et al.. (2005). Conservative management of a myxoid endometrial stromal sarcoma in a 16-year-old nulliparous woman. Gynecologic Oncology. 99(1). 243–245. 41 indexed citations
13.
Molpus, Kelly L., et al.. (2004). Endometrial adenocarcinoma within a single horn of a didelphic uterus: a report of 2 cases.. PubMed. 49(2). 123–5. 16 indexed citations
14.
15.
Remmenga, Steven W., et al.. (1994). Continuous Infusion Chemotherapy as a Radiation-Enhancing Agent for Yttrium-90-Radiolabeled Monoclonal Antibody Therapy of a Human Tumor Xenograft. Gynecologic Oncology. 55(1). 115–122. 14 indexed citations
16.
Remmenga, Steven W., et al.. (1992). Radical vulvectomy with partial rectal resection and temporary colostomy as primary therapy for selected patients with vulvar carcinoma. International Journal of Gynecology & Obstetrics. 38(2). 148–149. 8 indexed citations
17.
Barnhill, Danny, et al.. (1991). Intestinal surgery performed on gynecologic cancer patients. Gynecologic Oncology. 40(1). 38–41. 12 indexed citations
18.
Remmenga, Steven W., et al.. (1991). A technique for managing terminally III ovarian carcinoma patients. Gynecologic Oncology. 41(1). 88–91. 13 indexed citations
19.
Barnhill, Danny, et al.. (1991). Indwelling epidural catheters for pain control in gynecologic cancer patients.. PubMed. 77(4). 642–4. 9 indexed citations
20.
Alvero, Ruben, Steven W. Remmenga, Dennis O’Connor, Danny Barnhill, & Robert M. Park. (1990). Metastatic placental site trophoblastic tumor. Gynecologic Oncology. 37(3). 445–449. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L. Moretti Breakdown of academic impact, for papers by Dilu Feng Breakdown of academic impact, for papers by Bibo Yuan Breakdown of academic impact, for papers by Mingzi Tan Breakdown of academic impact, for papers by Bilan Li Breakdown of academic impact, for papers by Nana Tchabo Breakdown of academic impact, for papers by Shogo Shigeta Breakdown of academic impact, for papers by Gemma Toledo Breakdown of academic impact, for papers by Songshu Xiao Breakdown of academic impact, for papers by Xiangdong Hua
Rankless by CCL
2026